34 related articles for article (PubMed ID: 1775249)
1. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha from peripheral blood mononuclear cells of IgA nephropathy and mesangial cell proliferation.
Lee TW; Ahn JH; Park JK; Ihm CG; Kim MJ
Korean J Intern Med; 1994 Jan; 9(1):1-8. PubMed ID: 8038141
[TBL] [Abstract][Full Text] [Related]
3. Colocalization of IgG and IgA Heavy Chains with Kappa and Lambda Light Chains in Glomerular Deposits of IgA Nephropathy Patients Using High-Resolution Confocal Microscopy and Correlation with Oxford MEST-C Scores.
Rizk DV; Novak L; Hall SD; Moldoveanu Z; Julian BA; Novak J; Haas M
J Clin Med; 2023 Nov; 12(23):. PubMed ID: 38068413
[TBL] [Abstract][Full Text] [Related]
4. IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease.
Mestecky J; Julian BA; Raska M
Front Immunol; 2023; 14():1085922. PubMed ID: 36865536
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of idiopathic IgA nephropathy.
Williams DG
Pediatr Nephrol; 1993 Jun; 7(3):303-11. PubMed ID: 8518104
[TBL] [Abstract][Full Text] [Related]
6. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
Tamouza H; Vende F; Tiwari M; Arcos-Fajardo M; Vrtovsnik F; Benhamou M; Monteiro RC; Moura IC
Contrib Nephrol; 2007; 157():144-7. PubMed ID: 17495453
[TBL] [Abstract][Full Text] [Related]
7. Structural features of IgA molecules which contribute to IgA nephropathy.
Feehally J; Allen AC
J Nephrol; 1999; 12(2):59-65. PubMed ID: 10378660
[TBL] [Abstract][Full Text] [Related]
8. Analysis of charge distribution of lambda- and kappa-IgA in IgA nephropathy by focused antigen capture immunoassay.
Suen KK; Lewis WH; Lai KN
Scand J Urol Nephrol; 1997 Jun; 31(3):289-93. PubMed ID: 9249895
[TBL] [Abstract][Full Text] [Related]
9. Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors.
Zachova K; Jemelkova J; Kosztyu P; Ohyama Y; Takahashi K; Zadrazil J; Orsag J; Matousovic K; Galuszkova D; Petejova N; Mestecky J; Raska M
J Am Soc Nephrol; 2022 May; 33(5):908-917. PubMed ID: 35115327
[TBL] [Abstract][Full Text] [Related]
10. Light-chain ratio of serum IgA1 in IgA nephropathy.
Chui SH; Lam CW; Lewis WH; Lai KN
J Clin Immunol; 1991 Jul; 11(4):219-23. PubMed ID: 1918269
[TBL] [Abstract][Full Text] [Related]
11. Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.
Lai KN; To WY; Li PK; Leung JC
Kidney Int; 1996 Mar; 49(3):839-45. PubMed ID: 8648928
[TBL] [Abstract][Full Text] [Related]
12. Predominant synthesis of IgA with lambda light chain in IgA nephropathy.
Lai KN; Chui SH; Lai FM; Lam CW
Kidney Int; 1988 Feb; 33(2):584-9. PubMed ID: 3129610
[TBL] [Abstract][Full Text] [Related]
13. Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy.
Chen N; Nusbaum P; Halbwachs-Mecarelli L; Lesavre P
Nephrol Dial Transplant; 1991; 6(11):846-50. PubMed ID: 1775249
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
